New Delhi-based healthcare startup Genefitletics has bagged an undisclosed amount in a pre-seed funding round. A host of undisclosed angel investors had backed the startup. It pull-off the fresh funning round at a pre-money valuation of Rs 7.5 crore ($0.9 million).
The company, in a statement, said that it will deploy the fresh proceeds for product development and expansion.
Genefitletics, founded in 2019 by Sushant Kumar, claims to have developed a platform that collects and analyses molecular data using machine learning to understand the cause of health issues such as chronic diseases, cancer, infertility, preterm births, and recurrent infections. Furthermore, it creates medications to block or suppress such disorders.